Roberta Longo

1.0k total citations
35 papers, 392 citations indexed

About

Roberta Longo is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, Roberta Longo has authored 35 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hepatology, 8 papers in Epidemiology and 6 papers in Rheumatology. Recurrent topics in Roberta Longo's work include Hepatitis C virus research (10 papers), Hepatitis B Virus Studies (5 papers) and Systemic Lupus Erythematosus Research (5 papers). Roberta Longo is often cited by papers focused on Hepatitis C virus research (10 papers), Hepatitis B Virus Studies (5 papers) and Systemic Lupus Erythematosus Research (5 papers). Roberta Longo collaborates with scholars based in Italy, United Kingdom and United States. Roberta Longo's co-authors include Maria Rosaria Capobianchi, Giuseppina Cappiello, Alberto Spanò, Isabella Abbate, Claire Hulme, Oreste Lo Iacono, V. Di Marco, Anne‐Marie Bagnall, Martin Underwood and Susanne Finnegan and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Journal of Hepatology.

In The Last Decade

Roberta Longo

31 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberta Longo Italy 10 165 122 59 50 42 35 392
David Jegou France 13 151 0.9× 78 0.6× 28 0.5× 46 0.9× 8 0.2× 25 486
J. Santoro United States 6 290 1.8× 318 2.6× 56 0.9× 50 1.0× 40 1.0× 7 502
V. James United Kingdom 15 188 1.1× 183 1.5× 19 0.3× 42 0.8× 39 0.9× 31 592
Hans Vandenberghe Belgium 11 151 0.9× 93 0.8× 21 0.4× 48 1.0× 30 0.7× 27 434
Awatif Alam Saudi Arabia 13 89 0.5× 43 0.4× 13 0.2× 44 0.9× 38 0.9× 25 535
Gamal Chehab Germany 16 48 0.3× 28 0.2× 19 0.3× 51 1.0× 425 10.1× 58 657
Raghav Gupta United States 10 140 0.8× 34 0.3× 45 0.8× 23 0.5× 33 0.8× 67 358
Leonie Penna United Kingdom 14 76 0.5× 75 0.6× 93 1.6× 18 0.4× 13 0.3× 34 535
Viraj C. Kariyawasam Australia 17 379 2.3× 39 0.3× 38 0.6× 27 0.5× 24 0.6× 58 834
Neel Heerasing United Kingdom 12 221 1.3× 61 0.5× 66 1.1× 11 0.2× 12 0.3× 23 443

Countries citing papers authored by Roberta Longo

Since Specialization
Citations

This map shows the geographic impact of Roberta Longo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Longo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Longo more than expected).

Fields of papers citing papers by Roberta Longo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Longo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Longo. The network helps show where Roberta Longo may publish in the future.

Co-authorship network of co-authors of Roberta Longo

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Longo. A scholar is included among the top collaborators of Roberta Longo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Longo. Roberta Longo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Longo, Roberta, et al.. (2025). TearCare system versus cyclosporine ophthalmic emulsion for the treatment of moderate-to-severe meibomian gland disease associated dry eye disease in the United States: a cost-utility analysis. Expert Review of Pharmacoeconomics & Outcomes Research. 25(8). 1239–1247. 1 indexed citations
2.
Neto, João Seda, et al.. (2025). Nutritional management and outcomes of malnourished children under 2 years with intestinal failure. Journal of Pediatric Gastroenterology and Nutrition. 80(5). 880–888.
3.
4.
Roccatello, Dario, et al.. (2024). #2244 Safety and efficacy of daratumumab monotherapy in lupus nephritis refractory to conventional and rescue therapies. Nephrology Dialysis Transplantation. 39(Supplement_1).
5.
Geraci, Giovanni, et al.. (2023). #5348 THE EFFECTS OF RITUXIMAB IN NON-HCV-RELATED MIXED CRYOGLOBULINEMIC VASCULITIS. Nephrology Dialysis Transplantation. 38(Supplement_1).
6.
7.
8.
Keen, Justin, Natalie King, Judy Wright, et al.. (2020). Effects of interorganisational information technology networks on patient safety: a realist synthesis. BMJ Open. 10(10). e036608–e036608. 2 indexed citations
9.
Keen, Justin, Natalie King, Judy Wright, et al.. (2020). The effects of interoperable information technology networks on patient safety: a realist synthesis. SHILAP Revista de lepidopterología. 8(40). 1–162. 1 indexed citations
10.
Keen, Justin, Joanne Greenhalgh, Rebecca Randell, et al.. (2019). Networked information technologies and patient safety: a protocol for a realist synthesis. Systematic Reviews. 8(1). 307–307. 5 indexed citations
11.
Howard, Dena, Talha Munir, Lucy McParland, et al.. (2017). Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLL. Leukemia. 31(11). 2416–2425. 21 indexed citations
12.
Longo, Roberta, Paul D. Baxter, Peter Hall, et al.. (2014). Methods for Identifying the Cost-effective Case Definition Cut-Off for Sequential Monitoring Tests: An Extension of Phelps and Mushlin. PharmacoEconomics. 32(4). 327–334. 4 indexed citations
13.
South, Jane, Anne‐Marie Bagnall, Claire Hulme, et al.. (2014). A systematic review of the effectiveness and cost-effectiveness of peer-based interventions to maintain and improve offender health in prison settings. SHILAP Revista de lepidopterología. 2(35). 1–218. 46 indexed citations
14.
Longo, Roberta, et al.. (2010). Appearance of HbeAg in an Occult Persistent Hepatitis B Virus Infection. Intervirology. 53(3). 173–175. 6 indexed citations
15.
Svicher, Valentina, Caterina Gori, Valeria Micheli, et al.. (2008). The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypes. Journal of Hepatology. 50(3). 461–470. 31 indexed citations
16.
Abbate, Isabella, Oreste Lo Iacono, Roberta Longo, et al.. (2004). Heterogeneity of HVR-1 quasispecies is predictive of early but not sustained virological response in genotype 1b-infected patients undergoing combined treatment with PEG- or STD-IFN plus RBV.. PubMed. 17(2). 162–5. 5 indexed citations
17.
Abbate, Isabella, Giuseppina Cappiello, Roberta Longo, et al.. (2004). Cell membrane proteins and quasispecies compartmentalization of CSF and plasma HIV-1 from aids patients with neurological disorders. Infection Genetics and Evolution. 5(3). 247–253. 19 indexed citations
18.
Abbate, Isabella, Giuseppina Cappiello, Giorgio Antonucci, et al.. (2004). Intra-hepatic messenger RNA levels for interferons and related genes in hepatitis C virus/HIV co-infected patients. AIDS. 18(4). 691–692. 7 indexed citations
19.
Abbate, Isabella, Oreste Lo Iacono, R. Di Stefano, et al.. (2004). HVR-1 quasispecies modifications occur early and are correlated to initial but not sustained response in HCV-infected patients treated with pegylated- or standard-interferon and ribavirin. Journal of Hepatology. 40(5). 831–836. 37 indexed citations
20.
Abbate, Isabella, Mario Romano, Roberta Longo, et al.. (2003). Endogenous levels of mRNA for IFNs and IFN‐related genes in hepatic biopsies of chronic HCV‐infected and non‐alcoholic steatohepatitis patients. Journal of Medical Virology. 70(4). 581–587. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Jegou Breakdown of academic impact, for papers by J. Santoro Breakdown of academic impact, for papers by V. James Breakdown of academic impact, for papers by Hans Vandenberghe Breakdown of academic impact, for papers by Awatif Alam Breakdown of academic impact, for papers by Gamal Chehab Breakdown of academic impact, for papers by Raghav Gupta Breakdown of academic impact, for papers by Leonie Penna Breakdown of academic impact, for papers by Viraj C. Kariyawasam Breakdown of academic impact, for papers by Neel Heerasing
Rankless by CCL
2026